Canada
S2B | 21-Jan-2014
Seattle to Brussels Network analysis of the European Commission’s note on “Investment Provisions in the EU-Canada free trade agreement”
Democracy Now | 28-Dec-2013
A court in Canada has ruled Ecuadorean farmers and fishermen can try to seize the assets of oil giant Chevron based on a 2011 decision in an Ecuadorean court found it liable for nearly three decades of soil and water pollution near oil wells, and said it had ruined the health and livelihoods of people living in nearby areas of the Amazon rainforest.
| 26-Nov-2013
Most trade lawyers across the country are lauding Canada’s ratification of the International Centre for Settlement of Investment Disputes Convention. But they glaze over the serious and far-reaching effects for Canadian public policy.
| 12-Nov-2013
Tthe Harper government recently committed Canada to ratify the ICSID Convention.
| 9-Nov-2013
Since announcing the Comprehensive Economic and Trade Agreement (CETA) two weeks ago Harper’s Conservatives have repeatedly labelled those questioning the deal as “anti-trade”. But this Canada-European Union accord is one part trade and four parts ‘corporate bill of rights’.
| 3-Nov-2013
Canada has confirmed its ratification of the World Bank’s ICSID Convention by depositing its “Instrument of Ratification” with the International Centre for Settlement of Investment Disputes on Nov. 1, 2013.
La República, Perú | 3-Oct-2013
Las demandas de arbitraje contra los Estados por parte de los inversionistas son uno de los más importantes “súper derechos” que les confieren los TLC. Uno de sus usos más perversos de estos derechos es la posibilidad de ejercer presión contra los Estados, para que retrocedan en las medidas asumidas, amenazándolos con el inicio de un arbitraje.
Mondaq | 4-Sep-2013
In a recent NAFTA Investor-State claim brought against the United States by Apotex Inc., Canada’s largest producer of generic drugs, the Tribunal upheld the US’ preliminary objections to jurisdiction on the grounds that the company’s efforts to win approval for generic drugs in the US market did not make it an "investor" under NAFTA Chapter Eleven.
Globe and Mail | 17-Jul-2013
US pharmaceutical giant Eli Lilly and Co. has escalated a challenge it launched last year against Canada’s patent rules under the North American free-trade agreement, and is now demanding $500-million in compensation after the company lost its Canadian patents on two drugs.
Mining Weekly | 28-May-2013
Vancouver-based South American Silver (SAS), which early in May filed for arbitration against the Bolivian government over the cancellation of mineral tenements in 2012, has entered into a privileged arbitration funding agreement with an international investment fund specialising in such proceedings.